Nefopam Jelfa (Nefopam Hydrochloride)

Nefopam, the active ingredient in Nefopam Jelfa, is a non‑opioid centrally acting analgesic presented as an oral tablet for oral use. It provides analgesia for acute postoperative pain, musculoskeletal pain and other moderate to severe pain where opioid use is to be avoided.

GNH USA supplies Nefopam Jelfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with sourcing from the European Union market.

Nefopam is used to manage pain conditions that require moderate to severe analgesia without opioid therapy. - Acute postoperative pain: reduces pain intensity after surgical procedures. - Musculoskeletal pain: alleviates pain associated with strains, sprains, and inflammatory conditions. - Moderate to severe non‑opioid‑preferred pain: provides effective relief when opioid use is to be avoided.

Nefopam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: occasional upset stomach and vomiting. - Dry mouth: reduced salivation leading to throat discomfort. - Sweating: increased perspiration, especially in warm environments. - Dizziness: light‑headed sensation, often transient. - Constipation: slowed bowel movements. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Tachycardia: rapid heart rate that may require monitoring. - Seizures: rare occurrence, particularly in predisposed individuals. - Severe hypotension: marked drop in blood pressure causing faintness. - Allergic reactions: rash, itching, or swelling of face and throat. - Agranulocytosis: extremely rare drop in white blood cells.

Before prescribing nefopam, clinicians should consider several safety factors. - Renal function assessment: adjust use in patients with impaired kidney function. - Blood pressure monitoring: watch for hypertension or hypotension. - Seizure history: avoid in individuals with a known seizure disorder. - Elderly patients: start at lower doses and monitor for confusion. - Discontinuation: do not stop abruptly without medical advice. - Store at ambient temperature: keep in the original pack, protect from moisture.

Nefopam can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs): potential serotonin syndrome. - Tricyclic antidepressants: increased risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance blood pressure‑lowering effects. - Antipsychotics: possible additive central nervous system depression. - Other analgesics (e.g., NSAIDs): monitor for cumulative side effects. - Alcohol: may increase dizziness and hypotension.